Newly Established Veterinary Drugs Company Investment Opportunity in South San Francisco, USA
Developing supervision-free drug delivery for pets to replace the demands of daily dosing with pills/topicals.
Premium Plan
| Established | 0-1 year(s) |
| Employees | 2 - 5 |
| Legal Entity | C Corporation |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Veterinary Drugs |
| Locations | South San Francisco |
| Local Time | 7:10 PM America / Los Angeles |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
1 million
for
5.0%
stake
(Native Currency: USD 1,000,000)
Reason: Seeking investment to begin optimization of formulation of LS-001 pain treatment for dogs, engage re...
View More
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Company Presentation
(982.6 KB)
The CEO
(50.9 KB)
Domain-Verification.pdf
(213.3 KB)
Our CEO and Peanut
(95.9 KB)
Our CAO and Kewpie
(65.3 KB)
Certificate of Incorporation
(296.6 KB)
Business Overview
- Business focused on developing a portfolio of supervision-free medications for pets.
- The current product is a long-acting injectable designed to control pain in dogs with bone cancer.
- This product can also be prescribed off-label for other painful conditions in pets.
- The company plans to expand this drug delivery system to treat other conditions.
- The drug delivery platform is based on technology originally developed for humans, and the CEO was part of the development team.
- The company’s goal is to remove the burden of dosing, ensure adherence to prescriptions, and provide greater comfort to sick pets.
- Formulation, manufacturing and marketing is all outsourced.
- The company has developed prototypes of their products but is yet to conduct clinical trials and obtain FDA licensing.
- The business model is business-to-business (B2B), with plans to sell directly to veterinarians.
- The current product is a long-acting injectable designed to control pain in dogs with bone cancer.
- This product can also be prescribed off-label for other painful conditions in pets.
- The company plans to expand this drug delivery system to treat other conditions.
- The drug delivery platform is based on technology originally developed for humans, and the CEO was part of the development team.
- The company’s goal is to remove the burden of dosing, ensure adherence to prescriptions, and provide greater comfort to sick pets.
- Formulation, manufacturing and marketing is all outsourced.
- The company has developed prototypes of their products but is yet to conduct clinical trials and obtain FDA licensing.
- The business model is business-to-business (B2B), with plans to sell directly to veterinarians.
Products & Services Overview
- Long-acting injectable to control pain in dogs with bone cancer.- Can be prescribed off-label by vets for other painful conditions.
- This drug delivery system will be applied to treat other conditions in pets.
- The vet pharma market is resilient and growing as pet ownership increases worldwide.
Assets Overview
No physical as the operations are currently virtual and drug manufacturing is outsourced.The value of our company is in the intellectual property of our proprietary drug delivery platform.
Facilities Overview
Not operating from a dedicated facility.We are a virtual company and will outsource to third party contractors the formulation, regulatory affairs and marketing.
These companies have been identified. Formulation will be done with contractor experienced in the development of long-acting injectables for human use.
Capitalization Overview
The business is funded by the officers of the company. Total loans outstanding is $193,000 and the major shareholder is the CEO with an ownership of 93%.
Recent Activity
-
Earlier than 15 daysIndividual Advisor, Mesquite, Financial Consultant connected with the Business
-
Earlier than 15 daysFunding Specialist, Coconut Creek, Financial Consultant connected with the Business
-
Earlier than 15 daysPresident, Healthcare, Dallas, Individual Investor / Buyer connected with the Business
Tags:
Newly Established Veterinary Drugs Company Investment Opportunity in South San Francisco, United States
·Invest in Newly Established Veterinary Drugs Company in South San Francisco, United States
·Newly Established Veterinary Drugs Company Investment Opportunity
·Investment Opportunity in South San Francisco, United States
·Invest in Newly Established Veterinary Drugs Company
·Invest in South San Francisco, United States
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
7 Investors already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 122,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses